These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 22687788
1. A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction. Sunami E, Usuda K, Nishiyama Y, Otori T, Katsura K, Katayama Y. Intern Med; 2012; 51(10):1187-93. PubMed ID: 22687788 [Abstract] [Full Text] [Related]
2. [Post-stroke depression]. Katayama Y, Usuda K, Nishiyama Y, Katsura K. Nihon Ronen Igakkai Zasshi; 2003 Mar; 40(2):127-9. PubMed ID: 12708044 [Abstract] [Full Text] [Related]
4. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K. Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464 [Abstract] [Full Text] [Related]
5. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP. J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826 [Abstract] [Full Text] [Related]
6. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Röjdmark S. Eur J Clin Pharmacol; 2000 May; 56(2):123-7. PubMed ID: 10877005 [Abstract] [Full Text] [Related]
10. Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. Shimodozono M, Kawahira K, Kamishita T, Ogata A, Tohgo S, Tanaka N. Int J Neurosci; 2002 Oct; 112(10):1173-81. PubMed ID: 12587520 [Abstract] [Full Text] [Related]
11. Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor. Silver H, Barash I, Odnopozov N, Jahjah N, Mizruhin A. Biol Psychiatry; 1996 Jul 01; 40(1):75-7. PubMed ID: 8780859 [No Abstract] [Full Text] [Related]
12. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile. Grözinger M, Härtter S, Wang X, Röschke J, Hiemke C, Rose DM. Arch Gen Psychiatry; 2000 Aug 01; 57(8):812-3. PubMed ID: 10920471 [No Abstract] [Full Text] [Related]
14. Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. Gothelf D, Rubinstein M, Shemesh E, Miller O, Farbstein I, Klein A, Weizman A, Apter A, Yaniv I. J Am Acad Child Adolesc Psychiatry; 2005 Dec 01; 44(12):1258-62. PubMed ID: 16292117 [Abstract] [Full Text] [Related]
19. Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients. Katoh Y, Uchida S, Kawai M, Takei N, Mori N, Kawakami J, Kagawa Y, Yamada S, Namiki N, Hashimoto H. Biol Pharm Bull; 2010 Dec 01; 33(12):1999-2002. PubMed ID: 21139240 [Abstract] [Full Text] [Related]